The Norrsken Foundation, a non-profit impact ecosystem “connecting founders with the capital, knowledge and network they need to make saving the world their business,” is launching a $3.22 (€3) million initiative to support Swedish startups developing psychedelic-assisted mental health treatment options.
“Norrsken Mind” is the name for the new psychedelic science initiative that has already raised over €3 million, and is certain that more capital will come in soon enough.
The funding joins other European funding efforts in the field, such as the latest $285 million private placement raised by London-based COMPASS Pathways (NASDAQ: CMPS).
See Also: Awakn Life Sciences Becomes Pure R&D …